Search

everythinglearnresearchcommunity

for

Search:↓

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

miR‑339‑5p can slow down hair follicle stem cell differentiation by targeting DLX5.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Hydroxychloroquine may help COVID-19 patients with lupus.

Testosterone replacement therapy significantly improved sexual interest and function in HIV+ men.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

A specific gene mutation causes a rare hair loss condition in a Chinese patient.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Suppressing the HGPS mutation may improve symptoms and suggest reversibility.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Brepocitinib reduces interferon signaling in hidradenitis suppurativa patients.

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Demodex folliculitis can occur in HIV patients on HAART, and treatment may involve topical creams or medication changes.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Using cidofovir cream for a rare skin disease can cause skin darkening.

A girl with symptoms like an autoimmune disorder actually had HIV and a fungal infection, which was hard to diagnose and treat, leading to her death.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Many drugs can cause lipid metabolism issues, and labels need better warnings.